Alenka Franko Selected Research

Gemcitabine

10/2012	DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
1/2012	The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alenka Franko Research Topics

Disease

16	Malignant Mesothelioma 03/2024 - 01/2012
9	Asbestosis 12/2023 - 06/2007
5	Neoplasms (Cancer) 10/2021 - 01/2012
2	Disease Progression 03/2024 - 01/2015
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Leukopenia 01/2019
1	Alopecia (Baldness) 01/2019
1	Carcinogenesis 03/2018

Drug/Important Bio-Agent (IBA)

14	AsbestosIBA 03/2024 - 06/2007
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2018 - 12/2008
2	Calbindin 2IBA 12/2023 - 10/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 01/2015
2	EnzymesIBA 01/2015 - 01/2008
2	Gemcitabine FDA Link 10/2012 - 01/2012
1	Aquaporin 1IBA 01/2019
1	SurvivinIBA 01/2015
1	ImmunosorbentsIBA 01/2015
1	Inhibitor of Apoptosis ProteinsIBA 01/2015
1	PlatinumIBA 10/2012
1	MesothelinIBA 01/2012
1	Tumor Biomarkers (Tumor Markers)IBA 01/2012
1	Peptides (Polypeptides)IBA 01/2012
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2011
1	Superoxides (Superoxide)IBA 01/2009
1	ManganeseIBA 01/2009
1	Superoxide DismutaseIBA 01/2009
1	CatalaseIBA 12/2008
1	TransferasesIBA 06/2007
1	Glutathione (Reduced Glutathione)IBA 06/2007

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 03/2024 - 01/2015
1	Combination Drug Therapy (Combination Chemotherapy) 10/2012